The 9697 electrophoretograms performed over an 8 year period were reviewed to identify the frequency and clinical associations of the finding of a prominent transthyretin band in serum or urine, the concentration of which was equal to or greater than a 64 mg/dL protein calibrator. All samples were electrophoresed at a constant 90 V using agarose gels with a barbital buffer pH 8' 6 and Ponceau S staining. Reference calibrators were used as standards to identify increased transthyretin bands and the patients' clinical records were subsequently reviewed.
SUMMARY. The 9697 electrophoretograms performed over an 8 year period were reviewed to identify the frequency and clinical associations of the finding of a prominent transthyretin band in serum or urine, the concentration of which was equal to or greater than a 64 mg/dL protein calibrator. All samples were electrophoresed at a constant 90 V using agarose gels with a barbital buffer pH 8' 6 and Ponceau S staining. Reference calibrators were used as standards to identify increased transthyretin bands and the patients' clinical records were subsequently reviewed.
High values were found in 46 patients' sera and a further nine patients' urines representing 0'57l1Jo of the total workload. Renal impairment was present in 58% of cases including those with chronic renal failure, the nephrotic syndrome and paraproteinaemia. The high levels were not persistent in three myeloma cases where there was a recovery in renal function following chemotherapy. In some nephrotics, a high urine transthyretin may be secondary to a general hepatic albumin and transport protein synthesis response to severe proteinuria. Why the serum transthyretin was elevated in many other cases remains unclear.
Additional key phrases: chronic renal failure; nephrotic syndrome; paraproteinaemia A transthyretin (formerly prealbumin) band may be seen migrating towards the anode ahead of albumin with good quality electrophoresis systems but it is usually not visualized in routine serum protein electrophoretograms using agarose gels or cellulose acetate membranes, and its low serum concentration is not quantifiable by densitometry. Zone electrophoresis is used to detect the specific pathological changes found with paraproteins, and with clinically significant o l-antitrypsin deficiency. It is also used as a screen for paraproteins, for detecting protein changes in liver disease and in the quantitation of monoclonal immunoglobulins where immunochemica1methods overestimate the level of pathological protein.l-' However, with the availability of quantitative kits for specific protein measurement, zone electrophoresis now has little to offer other than the identification and quantitation of paraproteins.
Transthyretin is used in nutritional assess-ment3.4 and is a negative acute phase reactant.
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It is produced in the liver and by cells in the choroid plexus." Variant transthyretin has been found in the cerebrospinal fluid (CSF) in familial amyloidotic polyneuropathy. 6 The serum level falls in inflammation, malignancy, cirrhosis, protein-losing enteropathy and zinc deficiency. In Hodgkin's disease and in some alcoholics? the level rises. This protein may be inherently 'amyloidogenic' and single point mutations of the transthyretin gene are associated with familial amyloid polyneuropathy and familial amyloid cardiomyopathv.! Published reference ranges for transthyretin include 10-40 mg/dL using radial immunodiffusiont; 18-36 mg/dL in Wallach's handbook'? and 30'5(4'5) mg/dL [(mean(SD») in Japan!' and there is a sex difference with males about 15% higher.P Raised levels of serum transthyretin seem to be largely ignored in the literature. We therefore reviewed our bank of serum electrophoretograms to determine the associations of the small number of readily visible prealbumin bands whose concentration was greater than the reference range and was equal to or greater than the highest calibrant used. Cases where there was a clear urinary transthyretin band are also reported.
METHODS
All 9697 serum and urine protein electrophoretograms performed in this laboratory over an 8 year period to 1992were reviewed. No specific requests for transthyretin estimation had been received during that period. The serum samples were applied to agarose gels and separation was performed using the Ciba Corning electrophoresis system at a constant 90 V using a barbital buffer pH 8' 6. The strips were stained with Ponceau S and scanned with the Corning 710 fluorometer/ densitometer (Ciba Corning Diagnostics Limited, Essex, England). Urine samples were preconcentrated x 100 using a Minicon B15 (Ami con Division, W R Grace and Co, Beverly, MA, USA) and then 'treated similarly to serum. Changes in transthyretin from possible short-term sample storage are inconsequential.'! The sensitivity of the zone electrophoresis for transthyretin was established, retrospectively. Two Atlantic Antibodies calibrators from INCSTAR (Stillwater, MN, USA) based on the College of American Pathologists reference preparation for serum proteins with values of 64 and 45 mg/dL and a third calibrator SPS-Ol with a value 28 mg/dL from the Sheffield Protein Reference Unit (England) were used to semiquantitate the transthyretin levels. The 28 mg/dL transthyretin calibrant, which is well within the reference range, was not visible on our system whereas the 45 mg/dL level, which is slightly above the upper reference limit, showed a faint trace and the raised 64 mg/dL level was clearly seen. Total protein was estimated by biuret on a Hitachi 737 autoanalyser. The patients' clinical notes were then reviewed where possible and any follow-up electrophoretograms were sought.
RESULTS
A clearly visible serum transthyretin band which appeared equal to or greater than the 64 mg/dL (0'64 giL) concentration of the highest protein calibrator was found in 46 patients. A urinary transthyretin band greater than 64 mg/dL was found in a further nine cases. Thus a transthyretin band was clearly increased in O' 570/0 of the total number of protein strips. Medical records were unavailable in nine and these patients were excluded from the analyses. Therefore we report on the remaining 45 cases (37 sera and eight urines). There were 28 men and 17 women with a median age of 69 ranging from 29 to 92 years. The lower age quartile was up to 59 years while the upper quartile was over 74. The principal and other clinical diagnoses are listed in Table 1 . To avoid duplication, patients with two principal diagnoses are listed once with the second condition treated as a separate 'other condition'. Thus renal impairment occurred in a total of 26 separate patients (58%) and this includes all those with chronic renal failure, those with nephrotic syndrome and eight of the myeloma patients. Four of the myeloma patients in renal failure had nephrotic type urines with a prominent transthyretin band. Only one patient had received dialysis treatment when the samples were taken. The serum creatinine in these cases ranged from 126 to 1005/LmoVL and the median value was 247 with the lower quartile up to 151 and the upper quartile above 470 !£IIloVL. Diabetes mellitus was present in five (11%) and rheumatoid arthritis in three with renal failure present in three of the former and one of the latter. Alcohol was a factor in five cases (11%) with renal failure present in three of these. In three of the myeloma patients with impaired renal function, the prominent transthyretin band initially present disappeared following chemotherapy and a return to normal of the plasma creatinine. In an obese woman with mild ischaemic heart disease, the high transthyretin band appeared a fortnight following treatment of a pneumonia during which she showed a brisk serum acute phase reaction with a low serum transthyretin. A female with rheumatoid arthritis also had a low grade acute phase serum protein reaction despite a high transthyretin. Follow-up specimens were not available in other cases. At the time of specimen collection, prednisone was being prescribed in a total of six patients (13%)-three with multiple myeloma, one with nephrotic syndrome, one diabetic with chronic renal failure and in one patient with rheumatoid arthritis, arterial hypertension and asthma.
The eight high urinary transthyretin cases were from four patients with myeloma, two with nephrotic syndrome, one with chronic renal failure and alcoholic hepatitis and one whose notes were irretrievable. All had heavy unselective proteinuria. The serum transthyretin levelsin these cases were in the upper normal range except in two myeloma patients where the serum transthyretin TABLE 
Principal clinical diagnosis and other conditions associated with increased transthyretin bands
Chronic renal failure (11) Principal clinical diagnosis Diabetes mellitus (1) Polymyalgia rheumatica (I) Renal amyloidosis (1) Other conditions Alcoholic hepatitis (3) Diabetes mellitus (2) Lung carcinoma (1) Proximal myopathy (1) Cold agglutinins (1) Depression (1) Multiinfarct dementia (1) Hypertension (I) Chronic renal failure (8) Nephrotic (4) 
Myeloma
Nephrotic syndrome Acute myeloid leukaemia Tuberculosis (7) Chronic renal failure SLE (1) Myocardial infarction (I)
Renal amyloidosis (1) Rheumatoid arthritis (1) Asthma (1) Post nephrectomy for hypernephroma (1) Neurological (3) Guillain-Barre (1) Depression (2) Alcoholism (2) 
Cirrhosis
(1) Cardiac failure (1) Bronchiectasis (1) Rheumatoid arthritis (2) Psoriasis (I) Hypertension (1) Asthma (1) Carcinoma (2) Lung (1) Gastrointestinal (1) Diabetes mellitus (2) Secondary Hyperparathyroidism (1) Parkinsonism (1) Buerger's disease (1) Angiooedema (I)
Arterial hypertension (1)
Obesity (1) Ischaemic heart disease (1) Pregnancy (I) Pulmonary embolism 3rd trimester (1) band was not visible; one had nephrotic syndrome with renal amyloidosis and polymyalgia rheumatica while the other was also diabetic with chronic renal failure.
DISCUSSION
In hospital laboratories, agarose gels are usually used routinely in serum protein separations as they give higher resolution than cellulose acetate and are cheaper than polyacrylamide gels which, because of a molecular sieving effect added to the separation due to charge, also give an extra degree of fractionation unnecessary for a screening procedure. In a selected method paper on agarose gel electrophoresis, the authors state that the proteins of the prealbumin zone are barely discernible unless inspected against a white background under reflected light and are diffusely demarcated and vary slightly in mobility." Other immunological and electrophoretic methods are available. l1 , l S, 16 In this laboratory, a faint transthyretin band at a level within the reference range, is often seen in routine protein strips. Using Ponceau S as the stain, a specific study of the transthyretin fraction by electrophoresis was more sensitive than ours showing a visible prealbumin band right through the reference range.l? Thyroxine-binding and a2-microglobulin-binding prealbumin are the only proteins normally found in this zone but a-lipoproteins may migrate to this band in secondary lipolysis or in disorders of intermediary triglyceride metabolism and this may be relevant in some diabetics. Albumin molecules with firmly bound acidic drug metabolites may also appear in this band.'! The indications for zone electrophoresis vary considerably between institutions.' This hospital is a referral centre for renal dialysis and transplantation and this may have introduced some selection bias towards renal diseases. Despite the limitations of the retrospective analysis of case notes and the number of misplaced records, this study indicates that the finding of a raised transthyretin is associated with significant renal impairment in over half of the cases. Why transthyretin with a molecular weight of 61 000 should rise in these cases in contrast to the usual decrease in serum albumin with a molecular weight of 65 000 is unclear. However, in the nephrotic syndrome, hypoalbuminaemia leads to increased hepatic synthesis of albumin and other transport proteins and may have contributed to the high transthyretin found in the urine of some patients with unselective proteinuria. The hypercholesterolaemia in this condition is usually considered to result from the accumulation of low density lipoproteins from the hepatic secretion of apo-B which is large enough to be retained by the diseased glomerulus. In patients with renal failure, a filtration effect is most likely and the transthyretin level returned to the normal range in one myeloma case where a recovery of renal function followed a chemotherapy induced reduction in the serum paraprotein. The low molecular weight ,82-microglobulin accumulates in long-term renal failure patients on haemodialysis and causes amylcidosls" but only one patient in this study had been dialysed before the sample for electrophoresis had been taken.
Monoclonal immunoglobulin light chains in myelomas may form amyloid fibrils and persist. Whether transthyretin has any contributory role in laying down amyloid fibrils in some myeloma patients is unclear but normal transthyretin may be fibrillogenic under certain conditions.l? The transthyretin levels in some primary amyloidosis cases were 35' 0(6' 5) mg/dL [mean(SD)] and in secondary amyloidosis due to rheumatoid disease.'! the levels were 25' 6(9' 8) mg/dL [mean(SD)]. Thus some of these cases have transthyretin levels above the normal range.
The plasma half life of transthyretin is variously quoted from < 12 h to 1· 9 days and the extent of any daily fluctuation in serum transthyretin within the individual is unknown. Transthyretin transports thyroxine and triiodothyronine and forms a 1 : 1 complex with retinol binding protein which transports vitamin A to its target cell. Some of the high values may represent levels outside the reference interval that are coincidental and do not necessarily indicate the presence of any disease.P Repeat strips were not available in most cases because the electrophoretograms were used largely for paraprotein screens. An increase in serum transthyretin of about 320/0 due to prolonged prednisone therapy was first described in 1965 in five patients with Graves' disease." This was confirmed in the following year by another small five patient study, and in two of the latter cases the transthyretin levels were in the same range as those reported here. 22 The steroid effect disappeared in 4-6 weeks. Six patients in this study were taking prednisone which may have contributed to their high levels.
The increased transthyretin band may be due to decreased catabolism or clearance, or increased secretion from the liver cells with or without an increase in the rate of synthesis. In a study of total parenteral nutrition, the acute phase response predominated over nutritional effects on transthyretirr" yet there were two patients in this study who were recovering from acute phase responses, one with pneumonia and another with rheumatoid arthritis. Why the serum transthyretin was increased in many of our cases remains unclear.
